Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 79.64

-0.2%

Jan 2 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2937)	6/15/2010 4:16:44 PM
From: Jibacoa	Read Replies (1) of 3722

SNTA is closing at the H for the day and up for five trading days on a roll.<g> It is closing above the resistance at the $4 level with volume above its ADV. bigcharts.marketwatch.com It announced at the ASCO meeting last week clinical results for two PIs of STA-9090 in solid tumors, as well as 12 month updated survival results from the SYMMETRY trial of elesclomol in metastatic melanoma. The stock is trading above the ACTAY of $3.88 In spite of lower revenues on the 1stQ SNTA was able to trim its loss for 2nd time on a roll. It has low LTD and +FCF. The insiders reportedly hold a god % of the stock. The stock is not off from its Dec18 H at $6.95 but it seems that with some good news it could get back to the $6 level, which would be a 50% gain.<g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next